Cuba encouraged by early efficacy results of homegrown COVID-19 vaccine | Reuters

Cuba encouraged by early efficacy results of homegrown COVID-19 vaccine | Reuters: Cuba's Soberana 2 vaccine candidate has shown 62% efficacy with just two of its three doses, state-run biopharmaceutical corporation BioCubaFarma said on Saturday, citing preliminary data from late phase trials.